Bicycle Therapeutics Plc (BCYC)
4.89
-0.16
(-3.17%)
USD |
NASDAQ |
Apr 06, 16:00
4.885
0.00 (0.00%)
After-Hours: 20:00
Bicycle Therapeutics SG&A Expense (TTM) : 79.52M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | 6.375M |
| Mereo BioPharma Group Plc | 23.06M |
| Autolus Therapeutics Plc | 131.95M |
| NuCana Plc | 10.74M |
| DBV Technologies SA | 36.08M |